SCHEMBL1389283

SCHEMBL1389283

CCCOc1[c]c2ccccc2cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.37
MCHR1 Q99705 1/20 0.37
GPBAR1 Q8TDU6 1/20 0.36
CYSLTR1 Q9Y271 1/20 0.36
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
TSHR P16473 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
TDP1 Q9NUW8 3/20 0.33
GAA P10253 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 4/20 0.31
HTR1B P28222 2/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA6 P23280 1/20 0.31
CA5A P35218 1/20 0.31
CA7 P43166 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2256189 0.91 L3MBTL1 (0.41) TLR8MCHR1GPBAR1CYSLTR1TSHR
SCHEMBL1396371 0.90 LTA4H (0.41) TLR8MCHR1GPBAR1CYSLTR1MEN1
SCHEMBL2456698 0.88 MCHR1 (0.41) TLR8MCHR1GPBAR1CYSLTR1MEN1
SCHEMBL2458064 0.88 MCHR1 (0.41) TLR8MCHR1GPBAR1CYSLTR1MEN1
SCHEMBL6283599 0.88 MCHR1 (0.41) TLR8MCHR1GPBAR1CYSLTR1MEN1
SCHEMBL64412 0.85 ALDH1A1 (0.34) TLR8TDP1GAAL3MBTL1ALDH1A1
SCHEMBL2456166 0.85 NCF1 (0.41) MEN1KMT2ATSHRTDP1L3MBTL1
SCHEMBL1389303 0.85 GPBAR1 (0.40) TLR8MCHR1GPBAR1CYSLTR1KMT2A
SCHEMBL2214684 0.84 TSHR (0.39) TSHRTDP1ALDH1A1CA2KDM4E
SCHEMBL4629557 0.82 AGXT (0.32) TDP1CA12CA1CA9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3625223-B1 PYRIMIDINE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2021-08-11 EP claimed
US-20200108068-A1 PYRIMIDINE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2020-04-09 US claimed
EP-3625223-A1 PYRIMIDINE DERIVATIVES Idorsia Pharmaceuticals Ltd (CH) 2020-03-25 EP claimed
CN-110621667-A Pyrimidine derivatives 爱杜西亚药品有限公司 2019-12-27 CN claimed
WO-2018210992-A1 PYRIMIDINE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2018-11-22 WO claimed
CN-105061505-A Catalyst ligand, catalyst, and preparation methods and application thereof USTC UNIV SCIENCE TECH CN 2015-11-18 CN claimed
CN-118160125-A Electrolyte, sodium ion secondary battery, battery module, battery pack, and electricity using device 宁德时代新能源科技股份有限公司 2024-06-07 CN disclosed
EP-3625223-B1 PYRIMIDINE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2021-08-11 EP disclosed
US-20200108068-A1 PYRIMIDINE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2020-04-09 US disclosed
EP-3625223-A1 PYRIMIDINE DERIVATIVES Idorsia Pharmaceuticals Ltd (CH) 2020-03-25 EP disclosed
CN-110621667-A Pyrimidine derivatives 爱杜西亚药品有限公司 2019-12-27 CN disclosed
WO-2018210992-A1 PYRIMIDINE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2018-11-22 WO disclosed
EP-2524686-B1 PIGMENTATION-PREVENTING OR -AMELIORATING AGENT POLA CHEM IND INC (JP) 2017-06-21 EP disclosed
US-4197120-A ELECTRICALLY PHOTOSENSITIVE PARTICLES CONTAINING COLORANT HAVING ABSORPTION MAXIMUM GREATER THAN 410 NANOMETERS EASTMAN KODAK COMPANY (US) 1980-04-08 US disclosed
US-4175961-A DISPERSION OF A POLYMER HAVING ALKYLIDENE DIARYLENE GROUPS, A PYRYLIUM-TYPE DYE SALT, AND A BIS(N,N-DISUBSTITUTED ANILINE DERIVATIVE AS A SENSITIZER EASTMAN KODAK COMPANY (US) 1979-11-27 US disclosed
US-4127412-A BIS(AMINOARYL)ALKANES EASTMAN KODAK COMPANY (US) 1978-11-28 US disclosed
US-4111693-A PYRYLIUM TYPE DYE SALT EASTMAN KODAK COMPANY (US) 1978-09-05 US disclosed
US-4092162-A Nitrogen containing polymers aelements EASTMAN KODAK COMPANY (US) 1978-05-30 US disclosed
US-4025341-A CONDENSATION POLYMER OF A TERTIARY AROMATIC AMINE, A SENSITIZER, AND A CARBONYL COMPOUND EASTMAN KODAK COMPANY (US) 1977-05-24 US disclosed
US-4012376-A Photosensitive colorant materials EASTMAN KODAK COMPANY (US) 1977-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200108068-A1 PYRIMIDINE DERIVATIVES PTGER1, PTGER4, PTGER2 TLR8 1586/4885MCHR1 3550/4885GPBAR1 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.